Acute Arsenic Poisoning Treated by Intravenous Dimercaptosuccinic Acid (DMSA) and Combined Extrarenal Epuration Techniques

REFERENCES

• Aposhian HV, Maiorino RM, Gonzalez-Ramirez D, Zuniga-Charles M, Xu Z, Hurlbut KM, Junco-Munoz P, Dart RC, Aposhian MM. Mobilization of heavy metals by newer, therapeutically useful chelating agents. Toxicology 1995; 97: 23–38
   PubMed Web of Science ®Google Scholar
• Muckter H, Liebl B, Reichl FX, Hunder G, Walther U, Fichtl B. Are we ready to replace dimercaprol (BAL) as an arsenic antidote?. Hum Exp Toxicol 1997; 16: 460–465
   PubMed Web of Science ®Google Scholar
• Graziano JH, Cuccia D, Friedheim E. The pharmacology of 2,3-dimercaptosuccinic acid and its potential use in arsenic poisoning. J Pharmacol Exp Ther 1978; 207: 1051–1055
   PubMed Web of Science ®Google Scholar
• Lenz K, Hruby K, Druml W, Eder A, Gaszner A, Kleinberger G, Pichler M, Weiser M. 2,3-dimercaptosuccinic acid in human arsenic poisoning. Arch Toxicol 1981; 47: 241–243
   PubMed Web of Science ®Google Scholar
• Buchet JP, Lauwerys R. Evaluation of exposure to inorganic arsenic in man. Analytical Techniques for Heavy Metals in Biological Fluids, S Facchetti. Elsevier, Amsterdam 1981; 75–90
   Google Scholar
• Aposhian HV. DMSA and DMPS? Water-soluble antidotes for heavy metal poisoning. Annu Rev Pharmacol Toxicol 1983; 23: 193–215
   PubMed Web of Science ®Google Scholar
• Graziano JH. Role of 2,3-dimercaptosuccinic acid in the treatment of heavy metal poisoning. Med Toxicol 1986; 1: 155–162
   PubMedGoogle Scholar
• McGown EL, Tillotson JA, Knudsen JJ, Dumlao CR. Biological behavior and metabolic fate of the BAL analogues DMSA and DMPS. Proc West Pharmacol Soc 1984; 27: 169–176
   PubMedGoogle Scholar
• Inns RH, Rice P, Bright JE, Marrs TC. Evaluation of the efficacy of dimercapto chelating agents for the treatment of systemic organic arsenic poisoning in rabbits. Hum Exp Toxicol 1990; 9: 215–220
   PubMed Web of Science ®Google Scholar
• Graziano JH, Lolacono NJ, Meyer P. Dose-response study of oral 2,3-dimercaptosuccinic acid in children with elevated blood lead concentrations. J Pediatr 1988; 113: 751–757
   PubMed Web of Science ®Google Scholar
• Graziano JH, Cuccia D, Friedheim E. The pharmacology of 2,3-dimercaptosuccinic acid and its potential use in arsenic poisoning. J Pharmacol Exp Ther 1978; 207: 1051–1055
   PubMed Web of Science ®Google Scholar
• Kreppel H, Reichl FX, Szinicz L, Fichtl B, Forth W. Efficacy of various dithiol compounds in acute arsenic poisoning in mice. Arch Toxicol 1990; 64: 387–392
   PubMed Web of Science ®Google Scholar
• Fournier L, Thomas G, Garnier R, Buisine A, Houze P, Pradier F, Dally S. 2,3-dimercaptosuccinic acid in the treatment of heavy metal poisoning in humans. Med Toxicol Adverse Drug Exp 1988; 3: 499–504
   PubMedGoogle Scholar
• Guha Mazumder DN, Ghoshal UC, Saha J, Santra A, De BK, Chatterjee A, Dutta S, Angle CR, Centeno JA. Randomized placebo-controlled trial of 2,3-dimercaptosuccinic acid therapy of chronic arsenicosis due to drinking arsenic-contaminated subsoil water. J Toxicol Clin Toxicol 1998; 36: 683–690
   PubMed Web of Science ®Google Scholar
• Wax PM, Thornton CA. Recovery from severe arsenic-induced peripheral neuropathy with 2,3-dimercapto-1-propanesulphonic acid. J Toxicol Clin Toxicol 2000; 38: 777–780
   PubMed Web of Science ®Google Scholar
• Kreppel H, Paepcke U, Thiermann H, Szinicz L, Reichl FX, Singh PK, Jones HM. Therapeutic efficacy of new dimercaptosuccinic acid (DMSA) analogues in acute arsenic trioxide poisoning in mice. Arch Toxicol 1993; 67: 580–585
   PubMed Web of Science ®Google Scholar
• Aposhian HV, Carter DE, Hoover TD, Hsu CA, Maiorino RM, Stine E. DMSA, DMPS, and DMPA as arsenic antidotes. Fundam Appl Toxicol 1984; 4: S58–S70
   PubMedGoogle Scholar
• Kreppel H, Reichl FX, Kleine A, Szinicz L, Singh PK, Jones MM. Antidotes efficacy of newly synthesized dimercaptosuccinic acid (DMSA) monoesters in experimental arsenic poisoning in mice. Fundam Appl Toxicol 1995; 26: 239–245
   PubMedGoogle Scholar
• Buchwald AL. Intentional overdose of dimercaptosuccinic acid in the course of treatment for arsenic poisoning. J Toxicol Clin Toxicol 2001; 39: 113–114
   PubMed Web of Science ®Google Scholar
• Xue H, Ni W, Xie Y, Cao T. Comparison of lead excretion of patients after injection of five chelating agents. Chung Kuo Yao Li Hsuch Pao 1982; 3: 41–44
   PubMedGoogle Scholar
• Zhang J. Clinical observations in ethyl mercury chloride poisoning. Am J Ind Med 1984; 5: 251–258
   PubMed Web of Science ®Google Scholar
• Klimmek R, Krettek C, Werner HW. Acute effects of the heavy metal antidotes DMPS and DMSA on circulation, respiration, and blood homoeostasis in dogs. Arch Toxicol 1993; 67: 428–434
   PubMed Web of Science ®Google Scholar
• Hantson P, Mahieu P, Laterre PF, Lauwerys R, Bourlond A, Lachapelle JM. Skin manifestations accompanying acute arsenic poisoning and its treatment. J Toxicol Clin Exp 1992; 12: 311–315
   PubMedGoogle Scholar
• Sheabar FZ, Yannai S, Taitelman U. Efficiency of arsenic clearance from human blood in vitro and from dogs in vivo by extracorporeal complexing haemodialysis. Pharmacol Toxicol 1989; 64: 329–333
   PubMedGoogle Scholar
• Mathieu D, Mathieu-Nolf M, Germain-Alonso M, Nevière R, Furon D, Wattel F. Massive arsenic poisoning: effect of hemodialysis and dimercaprol on arsenic kinetics. Intensive Care Med 1992; 18: 47–50
   PubMed Web of Science ®Google Scholar
• Kruszewska S, Wiese M, Kolacinski Z, Mielczarska J. The use of haemodialysis and 2,3 propanesulphonate (DMPS) to manage acute oral poisoning by lethal dose of arsenic trioxide. Int J Occup Med Environ Health 1996; 9: 111–115
   PubMedGoogle Scholar
• Zilker T, Felgenhauer N, Pfab R, Drasch G, Roider G, Roos G. Little effect of haemodialysis and CAVHDF on the elimination of arsenic compared to DMPS treatment. J Toxicol Clin Toxicol 1999; 37: 400–401, Abstract
   Google Scholar
• Blythe D, Joyce DA. Clearance of arsenic by haemodialysis after acute poisoning with arsenic trioxide. Intensive Care Med 2001; 27: 334
   PubMed Web of Science ®Google Scholar
• Vaziri ND, Upham T, Barton CH. Hemodialysis clearance of arsenic. Clin Toxicol 1980; 17: 451–456
   PubMed Web of Science ®Google Scholar
• Smith SB, Wombolt DG, Venkatesan R. Results of hemodialysis and hemoperfusion in the treatment of acute arsenic ingestion. Clin Exp Dial Apheresis 1981; 5: 399–404
   PubMed Web of Science ®Google Scholar
• Giberson A, Vaziri ND, Mirahamadi K, Rosen SM. Hemodialysis of acute arsenic intoxication with transient renal failure. Arch Intern Med 1976; 136: 1303–1304
   PubMed Web of Science ®Google Scholar
• Reichl FX, Kreppel H, Szinicz L, Muckter H, Fichtl B, Forth W. Effect of various antidotes on the biliary and intestinal excretion of arsenic in situ and into the feces in vivo in guinea-pigs after injection of As2O3. Arch Toxicol 1994; 69: 35–38
   PubMed Web of Science ®Google Scholar